Search company, investor...

Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment / Other Medical Devices
merit.com

Investments

2

Partners & Customers

6

Service Providers

2

About Merit Medical Systems

Merit Medical Systems manufactures and markets disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. The company's primary products include inflation devices, guide wires, thrombolytic catheters, and fluid dispensing systems, and angiography accessories. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, trays and packs, coated tubes and wires, and sensor components for microelectromechanical systems. Merit Medical Systems was founded in 1987 and is based in South Jordan, Utah.

Headquarters Location

1600 West Merit Parkway

South Jordan, Utah, 84095,

United States

801-253-1600

Want to inform investors similar to Merit Medical Systems about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Merit Medical Systems News

Endoscopy Procedures Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Procedures [Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Submucosal Dissection (ESD), Peroral Endoscopic Myotomy (POEM), Endoscopic Ultrasound (EUS), Interventional Pulmonology and Laparoscopy, Arthroscopy and Bronchoscopy, Colonoscopy and Colposcopy, Proctoscopy and Thoracoscopy, and Others], Offering [Endoscopes, ERCP Accessories, Head positioner and Endotherapy Injection Needles, Sampling Device and Device Clip and Electrosurgical Knife, Endoscopic Ultrasound (EUS) Guided Devices, Guidewire, Forceps, Snare, Irrigation/Insufflation tubing systems, Probes, Hemostasis Clip, Polyp Traps, Single-Use Valves , Trocar sleeves and Tissue Scissors and Cutters, Retrieval Devices, and Others (Kits/Stents/Energy Devices/ Transport pad/Cleaning Brush/OT Lights, etc.)], Product Type (Disposable and Reusable), End User (Hospitals and Clinics, Ambulatory S

Sep 18, 2023

| Size & Share 2030 Endoscopy Procedures Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Procedures [Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Submucosal Dissection (ESD), Peroral Endoscopic Myotomy (POEM), Endoscopic Ultrasound (EUS), Interventional Pulmonology and Laparoscopy, Arthroscopy and Bronchoscopy, Colonoscopy and Colposcopy, Proctoscopy and Thoracoscopy, and Others], Offering [Endoscopes, ERCP Accessories, Head positioner and Endotherapy Injection Needles, Sampling Device and Device Clip and Electrosurgical Knife, Endoscopic Ultrasound (EUS) Guided Devices, Guidewire, Forceps, Snare, Irrigation/Insufflation tubing systems, Probes, Hemostasis Clip, Polyp Traps, Single-Use Valves , Trocar sleeves and Tissue Scissors and Cutters, Retrieval Devices, and Others (Kits/Stents/Energy Devices/ Transport pad/Cleaning Brush/OT Lights, etc. )], Product Type (Disposable and Reusable), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) Publication Month : Sep 2023 Market Insights and Analyst View: Endoscopic procedures are minimally invasive medical technique that involve inserting a thin, flexible tube into the body through natural openings or small incisions. These procedures allow doctors to visualize and operate on internal organs, tissues, and structures without the need of major surgeries. Endoscopy is majorly used for diagnosing and treating various conditions in areas such as gastrointestinal tract, respiratory systems and many more. Factors driving the growth of the endoscopy procedures market are growing preference for minimally invasive surgeries and increasing prevalence of cancer. The cost of the endoscopy machines can vary significantly based on the type of endoscope, the complexity of the equipment, the brand, the features it offers. The risks of infections associated with endoscopic procedures could hamper the growth of the market during the forecast period. Growth Drivers: Cancer is a major global public health problem and the leading cause of death in North America. Increasing gastrointestinal disorders and cancer cases in North America also accelerate the adoption of endoscopes and market growth. According to the American Cancer Society, colorectal cancer is the second most common cause of death in the US. The risk of developing this disease during the course of life is 4.3% in men and 4.0% in women. The American Cancer Society anticipated deaths of nearly 52,580 people in 2022 due to colorectal cancer in the US. According to Globocan 2020, the incidence of stomach cancer in Canada was 3,505 in 2020, which is expected to reach 5,230 by 2040. According to Statistics Canada, lung cancer is the most commonly diagnosed cancer and the leading cause of death in Canada than colorectal, pancreatic, and breast cancers combined. In 2021 alone, ~21,000 Canadians died of lung cancer. The high mortality rate from lung cancer reflects its low survival rate. Lung cancer incidence and mortality rates dramatically increase with age. Incidence rates peak among Canadians aged 75–84 years (396 per 100,000 people), while mortality rates are largely observed among Canadians aged 85 years and older (366 per 100,000 people). Overall, the lung cancer incidence rate is 1/10 higher among men than women, and the mortality rate is almost 1/3 higher among men than women. However, for Canadians younger than 55, rates are higher among women than men. Western countries, such as the US and Canada, report a high GI incidence rate due to increasing obesity in the adult population and less consumption of dietary fiber. As per the Centers for Disease Control and Prevention, December 2022, ~37.2 million cases of digestive system diseases are recorded in physician offices in the US. IBD is a term for two conditions—ulcerative colitis and Crohn's disease. Moreover, in the last few years, cases of IBD have increased worldwide due to a sedentary lifestyle; changing dietary habits; stress; and poor nutritional choices, including a high intake of ultra-processed foods and trans-fats. As per the Crohn’s & Colitis Foundation of America, around 70,000 new cases of IBD are diagnosed every year in the US. Further, chronic inflammation and reduced immunosurveillance caused due to IBD may contribute to the development of gastric cancer. This rising burden of cancer in Canada indicates the high requirement for endoscopic devices, thereby driving the market. Customize Research To Suit Your Requirement We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making. Market Size Value by Growth rate Forecast Period Have a question? Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any. Report Segmentation and Scope: The “Global Endoscopy Procedures Market” is segmented on the basis of procedure, offering, product type, and end user. Based on procedure, the market is categorized into endoscopic retrograde cholangiopancreatography (ERCP), endoscopic submucosal dissection (ESD), peroral endoscopic myotomy (POEM), endoscopic ultrasound (EUS), interventional pulmonology and laparoscopy, arthroscopy and bronchoscopy, colonoscopy and colposcopy, proctoscopy and thoracoscopy, and others. In terms of offering, the market is segmented into endoscopes, ERCP accessories, visualization system, head positioner and endotherapy injection needles, sampling device and device clip and electrosurgical knife, endoscopic ultrasound guided devices, guidewire, forceps, snare, irrigation/insufflation tubing systems, probes, hemostats clip, polyps traps, single-use valves, trocar sleeves and tissue scissors and cutters, retrieval devices, and others. The endoscopy procedures market, by product type, is bifurcated into disposable and reusable. The endoscopy procedures market, by end user, is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and others. The endoscopy procedures market, based on geography, is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). Download Free Sample Request discounts available for Start-Ups & Universities Segmental Analysis: Based on procedure, the endoscopy procedures market is segmented into is endoscopic retrograde cholangiopancreatography (ERCP), endoscopic submucosal dissection (ESD), peroral endoscopic myotomy (POEM), endoscopic ultrasound (EUS), interventional pulmonology and laparoscopy, arthroscopy and bronchoscopy , colonoscopy and colposcopy, proctoscopy and thoracoscopy, and others. In 2022, the arthroscopy and bronchoscopy segment held the largest share of the market. The endoscopic retrograde cholangiopancreatography (ERCP) segment is expected to grow at the fastest rate during the forecast period. Arthroscopy is a minimally invasive endoscopic offering for the diagnosis and surgical treatment of joint injuries. The essence of offering lies in the fact that the arthroscope is inserted into the joint cavity through 2 small incisions, which allows the surgeon to fully examine the joint, obtain information about its condition and identify the presence of intra-articular damage. Arthroscopy allows arthroscopic treatment of injuries of the knee joint. This technique allows you to remove the damaged part of the meniscus, restore ligaments, damaged cartilage and perform many other surgical interventions. Bronchoscopy is an endoscopic offering for examining the upper and lower (trachea, bronchi) respiratory tract using a bronchoscope. Based by offering, the market is segmented into endoscopes, ERCP accessories, visualization system, head positioner and endotherapy injection needles, sampling device and device clip and electrosurgical knife, endoscopic ultrasound guided devices, guidewire, forceps, snare, irrigation/insufflation tubing systems, probes, hemostats clip, polyps traps, single-use valves, trocar sleeves and tissue scissors and cutters, retrieval devices, and others. In 2022, the endoscopes segment held the largest share of the market. The ERCP accessories segment is expected to grow at the fastest rate during the forecast period. Based on end user, the market is divided into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and others. In 2022, the hospitals and clinics segment held the largest share of the market. The diagnostic laboratories segment is expected to grow at the fastest rate during the forecast period. Several endoscopic procedures are performed in hospitals and clinics, which can be used to diagnose and treat digestive disorders, including peptic ulcers, polyps, cancers, and blockages of the bile ducts caused by stones, inflammation, and tumors. The endoscopic clinics are specialized in treating bleeding issues from intestines, pre-cancerous abnormalities such as Barrett's esophagus, and familial adenomatous polyposis syndromes. The clinics also specialize in evaluating and developing new forms of endoscopes and endoscopic techniques. Thus, the factors mentioned above are driving the growth of the hospitals and clinics segment of the endoscopy procedure market. Endoscopy Procedures Market, by Product Type – 2022 and 2030 Request discounts available for Start-Ups & Universities Regional Analysis: Based on geography, the endoscopy procedures market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. The market in North America has been analyzed with a prime focus on three major countries—the US, Canada, and Mexico. The US is estimated to hold the largest endoscopy procedures market share during the forecast period. The rising healthcare expenditure is estimated to increase the adoption of various equipment for patient care, fueling the demand for endoscopy procedure products. According to the Global Burden of Disease Study published in October 2020, there is a high burden of various diseases in the US, such as colorectal cancer, cirrhosis, chronic kidney diseases, heart diseases, and cancer. Additionally, according to the US Department of Health and Human Services, 2021, chronic kidney disease (CKD) affects 1 in 7 US adults—i.e., an estimated 37 million Americans. The US endoscopy procedure market has recently witnessed several technological advancements and breakthroughs. The country has a broad pool of global endoscopy product manufacturers such as Boston Scientific Corp, PENTAX Medical, Stryker Corporation, and Steris Corporation. Therefore, the endoscope product approvals in the US fueled the market growth. In February 2023, Boston Scientific Corporation received US Food and Drug Administration (FDA) 510(k) clearance of the LithoVue Elite Single-Use Digital Flexible Ureteroscope System, the first ureteroscope system with the ability to monitor intrarenal pressure in real-time during ureteroscopy procedures. Thus, the need for facility and device sterilization rises with the surge in surgical procedures. Endoscopy Procedures Market Opportunity: The field of endoscopy in North America has witnessed various technological advancements and product launches. Such advancements are not only expected to help in the accurate diagnosis of a condition but also will help improve the safety of endoscopic procedures. Some recent technological advancements and product launches in the endoscopy devices market are listed below: In April 2021, Olympus announced the addition to its US bronchoscopy portfolio of the 510(k)-cleared H-SteriScope Single-Use Bronchoscopes, a line of five premium endoscopes for use in advanced diagnostic and therapeutic procedures. The introduction of the H-SteriScope portfolio has been a collaboration between Veran Medical Technologies, Inc., a wholly owned Olympus subsidiary, and Hunan Vathin Medical Instrument Co., Ltd. In April 2021, Ambu Inc. received Health Canada authorization for the aScope 4 Cysto, the company's unique flexible cystoscope platform for urology. Ambu’s aScope 4 Cysto is a cost-effective, high-quality flexible endoscope featuring excellent maneuverability and optics. Unlike traditional reusable endoscopes, single-use eliminates the significant capital, repair, and cleaning costs required to ensure a patient-ready instrument for every procedure. Each aScope 4 cystoscope is sterile from the package and ready when needed, enabling facilities to improve workflow efficiencies and reallocate staff from complex, time-consuming endoscope cleaning to more productive activities. Competitive Landscape and Key Companies: A few of the prominent endoscopy equipment manufacturers operating in the global endoscopic procedures market are Steris Plc, Conmed Corp, Olympus Corp, Boston Scientific Corp, PENTAX Medical  , Erbe Elektromedizin Gmbh, Micro-Tech Nanjing Co Ltd, Merit Medical Systems Inc, Cook Medical LLC, Stryker Corp, and Johnson & Johnson. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. For instance, in June 2022, Stryker opened its new research and development facility, Stryker’s Global Technology Centre, at the International Tech Park, Gurgaon. The 150,000-square-foot facility further supported the company’s mission to make healthcare better. Report Coverage Cook Medical Llc The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review. Data Collection and Secondary Research: As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain. Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends. Primary Research: The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team. For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise. A typical research interview fulfils the following functions: Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook Validates and strengthens in-house secondary research findings Develops the analysis team’s expertise and market understanding Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to: Industry participants: VPs, business development managers, market intelligence managers and national sales managers Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry. Below is the breakup of our primary respondents by company, designation, and region: Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection. Data Analysis: Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level. 3.1 Macro-Economic Factor Analysis: We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities. 3.2 Country Level Data: Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential. 3.3 Company Profile: The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size. 3.4 Developing Base Number: Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis. Data Triangulation and Final Review: The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization. We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports. We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time. Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out. Submit

Merit Medical Systems Investments

2 Investments

Merit Medical Systems has made 2 investments. Their latest investment was in NinePoint Medical as part of their Corporate Minority on May 5, 2018.

CBI Logo

Merit Medical Systems Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/1/2018

Corporate Minority

NinePoint Medical

Yes

1

3/6/2017

Series B

Subscribe to see more

Subscribe to see more

10

Date

5/1/2018

3/6/2017

Round

Corporate Minority

Series B

Company

NinePoint Medical

Subscribe to see more

Amount

New?

Yes

Subscribe to see more

Co-Investors

Sources

1

10

Merit Medical Systems Acquisitions

12 Acquisitions

Merit Medical Systems acquired 12 companies. Their latest acquisition was AngioDynamics - Dialysis catheters and sealant Business on June 09, 2023.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/9/2023

$99M

Acquired Unit

1

6/17/2019

Series B

$99M

$5.2M

Acquired

2

12/17/2018

$99M

Acquired

3

10/1/2018

Other Venture Capital

Subscribe to see more

$99M

$99M

Subscribe to see more

10

2/15/2018

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/9/2023

6/17/2019

12/17/2018

10/1/2018

2/15/2018

Investment Stage

Series B

Other Venture Capital

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$5.2M

$99M

Note

Acquired Unit

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

2

3

10

10

Merit Medical Systems Partners & Customers

6 Partners and customers

Merit Medical Systems has 6 strategic partners and customers. Merit Medical Systems recently partnered with Premier on June 6, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

6/11/2019

Client

United States

Merit Medical Awarded Interventional Fluid Management Agreement With Premier

SOUTH JORDAN , Utah , June 11 , 2019 -- Merit Medical Systems , Inc. , a leading manufacturer and marketer of proprietary disposable devices used in interventional , diagnostic and therapeutic procedures , particularly in cardiology , radiology , oncology , critical care and endoscopy , announced today that it has been awarded a group purchasing agreement for interventional fluid management products with Premier .

2

5/1/2018

Partner

United States

Subscribe to see more

Subscribe to see more

10

5/1/2018

Partner

United States

Subscribe to see more

Subscribe to see more

10

9/13/2017

Partner

United States

Subscribe to see more

Subscribe to see more

10

3/6/2017

Supplier

United States

Subscribe to see more

Subscribe to see more

10

Date

6/11/2019

5/1/2018

5/1/2018

9/13/2017

3/6/2017

Type

Client

Partner

Partner

Partner

Supplier

Business Partner

Country

United States

United States

United States

United States

United States

News Snippet

Merit Medical Awarded Interventional Fluid Management Agreement With Premier

SOUTH JORDAN , Utah , June 11 , 2019 -- Merit Medical Systems , Inc. , a leading manufacturer and marketer of proprietary disposable devices used in interventional , diagnostic and therapeutic procedures , particularly in cardiology , radiology , oncology , critical care and endoscopy , announced today that it has been awarded a group purchasing agreement for interventional fluid management products with Premier .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

Merit Medical Systems Service Providers

2 Service Providers

Merit Medical Systems has 2 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired, and Acquired Unit

Investment Bank

Financial Advisor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Associated Rounds

Acquired, and Acquired Unit

Subscribe to see more

Provider Type

Investment Bank

Subscribe to see more

Service Type

Financial Advisor

Subscribe to see more

Partnership data by VentureSource

Merit Medical Systems Team

3 Team Members

Merit Medical Systems has 3 team members, including former Chief Executive Officer, President, Greg Barrett.

Name

Work History

Title

Status

Greg Barrett

Chief Executive Officer, President

Former

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Greg Barrett

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer, President

Subscribe to see more

Subscribe to see more

Status

Former

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.